General Manager- DQ Corporate Restaurant
NGM Biopharmaceuticals, Inc. is a clinical stage biotech company dedicated to discovering and developing the next generation of medicines for the treatment of serious diseases. Our experienced scientific team has joined forces with an impressive group of industry professionals, Nobel Laureates and other distinguished researchers to form a company where innovation and cutting-edge science has provided the foundation for a robust drug discovery engine. To date, NGM Bio has generated a pipeline of seven drug candidates in various stages of development targeting liver, metabolic and ophthalmic diseases and cancer. The most advanced drug candidate, NGM282, is entering Phase 2b clinical studies in non-alcoholic steatohepatitis (NASH). NGM’s strategic collaboration with Merck, which was extended to March 2022, will continue to provide us with the resources and flexibility to pursue our ambitious R&D goals and further extend our pipeline of novel drug candidates.
Reporting to the Director of Clinical Operations, this position is responsible for assisting all aspects of the clinical development activities and interfacing with vendors and investigators to optimize program efficiency across each of NGM’s trials in NASH and other liver diseases, as appropriate. The successful candidate must have a good business acumen and some background in liver and/or metabolic diseases who has demonstrated well-rounded experiences in clinical trial execution, preferably from study start-up, trial initiation, maintenance and closure.
NGM values team players who are comfortable working with a shared resource pool and operating in a nimble, fast-paced environment.
Required Skills
The CRA / SCRA, Clinical Operations – Liver Disease will be part of the integral team to support the NGM282 (aldafermin) clinical development program, providing supports in timelines, budgets, planning and implementation of clinical trials and communications with vendors and sites.
Initial core duties and responsibilities of the CRA / SCRA, Clinical Operations – Liver Disease include:
Required Experience
PREFERRED QUALIFICATIONS
NGM offers a creative, collaborative, highly challenging scientific environment, along with a strong compensation package that includes salary, stock options, 401(k), ESPP and a comprehensive benefits package.
Interested applicants should apply through the NGM Biopharmaceuticals website: http://www.ngmbio.com/careers/#SilkroadFrame
The CRA / SCRA, Clinical Operations – Liver Disease will be part of the integral team to support the NGM282 (aldafermin) clinical development program, providing supports in timelines, budgets, planning and implementation of clinical trials and communications with vendors and sites.
Initial core duties and responsibilities of the CRA / SCRA, Clinical Operations – Liver Disease include: